Advertisement
Advertisement

HELP

H

Cybin Inc. Common Stock

5.31
USD
Sponsored
-0.03
-0.56%
May 08, 16:00 UTC -4
Closed
exchange

Pre-Market

5.32

+0.01
+0.19%

Cybin Inc. Common Stock Profile

About

Helus Pharma is a clinical stage pharmaceutical company. Its lead candidate includes HLP003 and HLP004. Helus Pharma, formerly known as Cybin Inc., is based in BOSTON.

Info & Links

CEO

Douglas Drysdale

Headquarters

100 KING STREET WEST, SUITE 5600
TORONTO, A6 M5X 1C9, CANADA

Industry

Medical Drugs

Sector

Medical

Website

www.cybin.com

Auditor

Laurence W. Zeifman, CPA, CA.

Share holders

--

Employees

50

Cybin Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

265.44M

Enterprise Value

70.31M

Enterprise Value/EBITDA(ttm)

-0.60

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.95

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-59.98%

Return on Invested Capital(ttm)

-60.94%

Return on Assets(ttm)

-50.80%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-117.54M

Net Income Available to Common(ttm)

-122.01M

Diluted EPS(ttm)

-4.23

Share Statistics

Beta (5Y Monthly)

0.77

52-Week Change

--

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

43.89M

% Held by Insiders

15.00%

% Held by Institutions

17.94%

Balance Sheet

Total Cash(mrq)

195.13M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

13.78%

Quick Ratio(mrq)

13.78%

Book Value Per Share(mrq)

5.49

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.26

Free Cash Flow(ytd)

-97.02M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement